Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-030897
Filing Date
2014-05-02
Accepted
2014-05-02 19:35:51
Documents
1
Period of Report
2014-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9872
  Complete submission text file 0001209191-14-030897.txt   11330
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 57 RUE DE RICHELIEU PARIS I0 75002
Business Address 57 RUE DE RICHELIEU PARIS I0 75002 33 967 15 8121
FCPR Biotechnology Fund (Reporting) CIK: 0001603990 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 0430
Type: 3 | Act: 34 | File No.: 001-36365 | Film No.: 14810968